Navigation Links
Advanced Market Research for Medical Device Manufacturers
Date:3/3/2011

DENVER, March 3, 2011 /PRNewswire-USNewswire/ -- AORN Works, a subsidiary of the Association of periOperative Registered Nurses (AORN), announced that its market research and surgical insights division will lead the strategic priorities of its business.

(Logo: http://photos.prnewswire.com/prnh/20101001/DC75398LOGO)

On behalf of clients, market research/surgical insights measure the attitudes of perioperative professionals who are the end users of medical products and services. The new strategy results from its niche ability to provide exceptional market intelligence to medical device manufacturers and service providers that sell to operating rooms throughout the United States.  

In addition to its market research division, AORN Works specializes in executive level interim and permanent placement services for perioperative departments.

"As a subsidiary of AORN, we have contact with more than 40,000 operating room professionals who we can use as a resource for our market research," said Vicki Faas, general manager for AORN Works.  "Through our opt- in market research database, we are also able to tap into a broad network of perioperative team members including OR nurses, management, scrub and central sterile technicians, surgeons and anesthesiologists."

AORN Works conducts research that translates into actionable information to expedite the development of products and services that benefit surgical patients in the ambulatory surgery and hospital settings.  Capabilities include market needs assessments, target market analysis, voice of the customer, product testing, strategic advisory boards, marketing communications development and testing, customer satisfaction and forecasting.

About AORN Works

Headquartered in Denver, Colo., AORN Works is a subsidiary of the Association of periOperative Registered Nurses (AORN), the nation's largest perioperative nursing association.  AORN Works' mission is to provide customers with expert resources and solutions grounded in AORN standards and recommended practices that will enhance safe patient care and support optimal outcomes in the perioperative setting.  Please visit www.AORNworks.org.


'/>"/>
SOURCE AORN Works
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
Breaking Medicine News(10 mins):